Indazole macrocycle polymorphs
NI202600038APending Publication Date: 2026-09-24BLOSSOMHILL THERAPEUTICS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- NI202600038
- Authority / Receiving Office
- NI · NI
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-06-05
- Publication Date
- 2026-09-24
Abstract
This disclosure relates to polymorphs of (17E)-16-ethyl-8,12,14-trimethyl-2,11,12,14-tetrahydro-8H-3,5-ethenotripyrazol[3,4-f:3',4'-j:4'',3''-n][1,4]oxazacyclopentadecin-13(10H)-one that are useful in the treatment of diseases, such as cancer, in mammals. This disclosure also relates to compositions that include such polymorphs and methods for using such compositions in the treatment of diseases, such as cancer, in mammals, especially humans.
Need to check novelty before this filing date? Find Prior Art